Skip to main content

News Archive

News Archive - Skaggs School of Pharmacy and Pharmaceutical Sciences

Digitized Number 2: Stool Samples Reveal Microbial Enzyme Driving Bowel Disease

January 27, 2022

Researchers at UC San Diego used a multi-omics approach to investigate stool samples from patients with ulcerative colitis, a chronic inflammatory bowel disease. The team has identified the family of microbiome-derived enzymes driving the disease, and demonstrated a potential therapeutic solution.

Six UC San Diego Experts Elected AAAS Fellows in 2021

January 26, 2022

Six researchers and leaders at the University of California San Diego have been named Fellows of the American Association for the Advancement of Science (AAAS), the largest general science organization in the world and publisher of the journal Science.

UC San Diego Receives $14M to Drive Precision Nutrition with Gut Microbiome Data

January 20, 2022

National Institutes of Health establishes Microbiome and Metagenomics Center at UC San Diego, part of new effort to predict individual responses to food and inform personalized nutrition recommendations.

Botox Injections May Reduce Anxiety

December 21, 2021

Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego discover that Botox injections may reduce anxiety.

Two UC San Diego Scientists Elected to National Academy of Medicine

October 18, 2021

Leaders in cell biology and anti-malarial drug development respectively, JoAnn Trejo and Elizabeth Winzeler were recognized by their peers with one of the highest honors in health and medicine.

How Cells “Read” Artificial Ingredients Tossed into Genetic Recipe

June 17, 2021

UC San Diego School of Medicine researchers discovered that the enzyme RNA polymerase II recognizes and transcribes artificially added base pairs in genetic code, a new insight that could help advance the development of new vaccines and medicines.

Common Diabetes Drug Shows Promise as Treatment for COVID-19 Lung Inflammation

June 8, 2021

Researchers identify molecular mechanism for the anti-inflammatory activity of diabetes drug metformin and, in mouse studies, say it prevents lung inflammation in animals infected with SARS-CoV-2, the virus that causes COVID-19.

Two Novel Biobanks Offer Investigatory Targets for Cocaine and Oxycodone Addiction

April 26, 2021

Researchers have created to novel biobanks of diverse tissues from animals to further explore the biological bases and consequences of addiction to cocaine and oxycodone.

Experimental Therapy for Parasitic Heart Disease May Also Help Stop COVID-19

April 2, 2021

UC San Diego researchers found that the chemical inhibitor K777 reduces the coronavirus’ ability to infect cell lines by blocking human enzyme cathepsin L; clinical trials are underway.

Repurposed Heart and Flu Drugs May Help Body Fight Sepsis

March 24, 2021

UC San Diego researchers discovered that patient survival from sepsis is associated with higher platelet counts, and identified two currently available drugs that protect these blood cells and improve survival in mice with sepsis.
Category navigation with Social links